Sumatriptan
Product Images NDC 67296-1224

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 67296-1224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

This is not available.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

Estimated Probability of Remedication or Rescue: 100% with various doses of medication. Not available.*

FDA Label Image

Package Label-principal Display Panel (25 mg (36 Tablets Bottle))

This text provides information about Sumatriptan Tablets containing 35 mg of sumatriptan succinate. It is distributed by Aurabindo Pharma USA, Inc. and made in India. The usual dosage information can be found in the package insert. The storage instructions recommend storing the tablets at 20° to 25°C with excursions permitted to 15° to 30°C. Each bottle contains 36 tablets.*

FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))

Not available.*

FDA Label Image

Package Label-principal Display Panel (50 mg (36 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))

This text appears to be a description of Sumatriptan Tablets, which are used for the treatment of migraine headaches. The tablets contain 70 mg of sumatriptan succinate USP, equivalent to 50 mg of sumatriptan. It provides instructions on dosage, administration, and storage conditions. The tablets are available in unit-dose packaging.*

FDA Label Image

Package Label-principal Display Panel (100 mg (36 Tablets Bottle))

This text appears to be the label information for a medication called Sumatriptan Tablets, USP, manufactured by AUROBINDO. Each tablet contains 140 mg of Sumatriptan succinate USP, which is equivalent to 10100 mg of sumatriptan. The recommended usage is to swallow the tablets whole with water. It is advised not to split the tablets. The storage temperature should be maintained between 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 85°F). The tablets are distributed by Aurobindo Pharma USA, Inc. and are made in India. Please refer to the package insert for detailed dosage information.*

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))

This text appears to be a label for Sumatriptan Tablets, which are used for treating migraines. It includes dosage information and instructions on how to take the tablets. The label also provides details like the manufacturer, strength of the medication, and how many tablets are in a package. Overall, it provides essential information for patients using this medication.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.